Rating History for Enliven Therapeutics (ELVN) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/12/2026 Michael Schmidt New Coverage Buy
(N/A)		 80.00
(N/A)		 40.75
(48.60)		 19.26% Details